62
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Burden of methicillin-resistant Staphylococcus aureus pneumonia among hospitalized patients in Lebanon and Saudi Arabia

, , , , , , , , , , & show all
Pages 49-55 | Published online: 02 Feb 2017

References

  • American Thoracic Society, Infectious Diseases Society of AmericaGuidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumoniaAm J Respir Crit Care Med2005171438841615699079
  • ZigmondJPecanLHájekPRaghubirNOmraniAMRSA infection and colonization rates in Africa and Middle East: a systematic review & meta-analysis16th International Congress on Infectious DiseasesCape Town2014
  • IyerAKumosaniTAzharEBarbourEHarakehSHigh incidence rate of methicillin-resistant Staphylococcus aureus (MRSA) among healthcare workers in Saudi ArabiaJ Infect Dev Ctries20148337237824619270
  • TokajianSNew epidemiology of Staphylococcus aureus infections in the Middle EastClin Microbiol Infect201420762462824861893
  • LiuCBayerACosgroveSEClinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and childrenClin Infect Dis20115213821148512
  • GouldIMCaudaREspositoSGudiolFMazzeiTGarauJManagement of serious meticillin-resistant Staphylococcus aureus infections: what are the limits?Int J Antimicrob Agents201137320220921300528
  • MorganMTreatment of MRSA soft tissue infections: an overviewInjury201142suppl 5S11S17
  • RodvoldKAMcConeghyKWMethicillin-resistant Staphylococcus aureus therapy: past, present, and futureClin Infect Dis201458suppl 1S20S2724343828
  • GeorgesHLeroyOAlfandariSPulmonary disposition of vancomycin in critically ill patientsEur J Clin Microbiol Infect Dis19971653853889228481
  • LodiseTPPatelNLomaestroBMRodvoldKADrusanoGLRelationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patientsClin Infect Dis200949450751419586413
  • PatelNPaiMPRodvoldKALomaestroBDrusanoGLLodiseTPVancomycin: we can’t get there from hereClin Infect Dis201152896997421460308
  • LiuCBayerACosgroveSEClinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and childrenClin Infect Dis2011523e18e5521208910
  • ChungDRSongJHKimSHAsian Network for Surveillance of Resistant Pathogens Study GroupHigh prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in AsiaAm J Respir Crit Care Med2011184121409141721920919
  • MuscedereJGShorrAFJiangXDayAHeylandDKCanadian Critical Care Trials GroupThe adequacy of timely empiric antibiotic therapy for ventilator-associated pneumonia: an important determinant of outcomeJ Crit Care2012273322.e7322.e14
  • ZilberbergMDShorrAFMicekSTHospitalizations with healthcare-associated complicated skin and skin structure infections: impact of inappropriate empiric therapy on outcomesJ Hosp Med20105953554020734456
  • MicekSTReichleyRMKollefMHHealth care-associated pneumonia (HCAP): empiric antibiotics targeting methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa predict optimal outcomeMedicine (Baltimore)201190639039522033455
  • ZilberbergMDShorrAFMicekSTModySHKollefMHAntimicrobial therapy escalation and hospital mortality among patients with health-care-associated pneumonia: a single-center experienceChest2008134596396818641103
  • Al-DorziHMEl-SaedARishuAHBalkhyHHMemishZAArabiYMThe results of a 6-year epidemiologic surveillance for ventilator-associated pneumonia at a tertiary care intensive care unit in Saudi ArabiaAm J Infect Control201240979479922317860